|
WO2021012014A1
|
|
Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
|
|
CA3105599A1
|
|
Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof
|
|
AU2018226610A1
|
|
Haloallylamine pyrazole derivative inhibitors of lysyl oxidases and uses thereof
|
|
US2019040007A1
|
|
Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
|
|
CA2841402A1
|
|
Improvements relating to delivery devices
|
|
EP2731571A1
|
|
Improvements relating to delivery devices
|
|
KR20140074277A
|
|
Improvements relating to delivery devices
|
|
KR20140014179A
|
|
Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine
|
|
GB201112668D0
|
|
Improvements relating to delivery devices
|
|
GB201112666D0
|
|
Improvements relating to delivery devices
|
|
GB201112667D0
|
|
Improvements relating to delivery devices
|
|
GB201112030D0
|
|
Improvements relating to delivery devices
|
|
GB201112031D0
|
|
Improvements relating to delivery devices
|
|
GB201112029D0
|
|
Improvements relating to delivery devices
|
|
KR20120049183A
|
|
Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
|
|
CA2706465A1
|
|
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
|
AU2001270356B2
|
|
Novel compounds and methods
|
